Kartik Konduri, M.D. | Texas Oncology

Dr. Kartik Konduri, MD

Claim this profile

Texas Oncology-Baylor Charles A. Sammons Cancer Center

Studies Lung Cancer
Studies Non-Small Cell Lung Cancer
12 reported clinical trials
23 drugs studied

Area of expertise

1

Lung Cancer

Kartik Konduri, MD has run 10 trials for Lung Cancer. Some of their research focus areas include:

Stage IV
Stage III
NRG1 positive
2

Non-Small Cell Lung Cancer

Kartik Konduri, MD has run 8 trials for Non-Small Cell Lung Cancer. Some of their research focus areas include:

Stage IV
Stage III
Progression

Affiliated Hospitals

Image of trial facility.

Texas Oncology - Baylor Charles A. Sammons Cancer Center

Image of trial facility.

Texas Oncology-Baylor Charles A. Sammons Cancer Center - USOR

Clinical Trials Kartik Konduri, MD is currently running

More about Kartik Konduri, MD

Clinical Trial Related

5 years of experience running clinical trials · Led 12 trials as a Principal Investigator · 3 Active Clinical Trials

Treatments Kartik Konduri, MD has experience with

  • Pemetrexed
  • Carboplatin
  • Placebo
  • Pembrolizumab
  • NovoTTF-200T
  • Seribantumab

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?

What does Kartik Konduri, MD specialize in?

Is Kartik Konduri, MD currently recruiting for clinical trials?

Are there any treatments that Kartik Konduri, MD has studied deeply?

What is the best way to schedule an appointment with Kartik Konduri, MD?

What is the office address of Kartik Konduri, MD?

Is there any support for travel costs?